Vaughan Nelson Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$286M Sell
238,515
-12,403
-5% -$12.7M 2.53% 2
2026
Q1
$231M Buy
250,918
+20,897
+9% +$21.2M 2.32% 3
2025
Q4
$247M Sell
230,021
-34,339
-13% -$32.8M 2.42% 4
2025
Q3
$202M Buy
+264,360
New +$197M 1.83% 11
2024
Q1
– Sell
-8
Closed -$5K – 231
2023
Q4
$5K Buy
+8
New +$4.67K ﹤0.01% 213

Other funds holding LLY

Vaughan Nelson Investment Management's LLY Position: Q2 2026 in Review

Vaughan Nelson Investment Management reduced its Eli Lilly (LLY) stake by 4.9% in Q2 2026, selling an estimated $12.7M and leaving 238,515 shares worth $286M. The position accounts for 2.53% of the portfolio, ranked #2.

Vaughan Nelson Investment Management first reported a position in LLY in Q4 2023 and has held it in 5 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Vaughan Nelson Investment Management held 238,515 shares of Eli Lilly worth $286M as of Q2 2026.
  • Vaughan Nelson Investment Management sold 12,403 Eli Lilly shares in Q2 2026, an estimated $12.7M.
  • Eli Lilly made up 2.53% of Vaughan Nelson Investment Management's portfolio in Q2 2026, its #2 holding.
  • Vaughan Nelson Investment Management first reported a position in Eli Lilly in Q4 2023 and has held it in 5 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Vaughan Nelson Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.